Stock Pick

3 ASX shares to buy before the next market rally

Written by

openjargon

in

A young man talks tech on his phone while looking at a laptop with a financial graph superimposed across the image.

Trying to time the market perfectly is almost impossible.

But what investors can do is position themselves ahead of improving conditions. When sentiment begins to shift, share prices often move quickly, and the biggest gains can come early in the recovery.

Right now, there are signs that confidence is starting to return. However, many high-quality ASX shares are still trading below their previous highs, which could present an opportunity for long-term investors.

Here are three ASX shares that could be worth buying before the next market rally.

CSL Ltd (ASX: CSL)

The first ASX share to consider before the next market rally is CSL.

CSL is one of the world’s highest-quality biotechnology companies, with a global presence across plasma therapies and vaccines. Its products are essential, and demand tends to remain strong regardless of economic conditions.

In recent periods, the company has faced headwinds, particularly around the key CSL Behring business. While not out of the woods just yet, these challenges appear to be easing, and CSL is well positioned to return to consistent growth in the near term.

If sentiment improves, CSL shares may respond quickly given how they are trading near multi-year lows.

ResMed Inc. (ASX: RMD)

Another ASX share that could be a top pick is ResMed.

It is a global leader in sleep disorder treatment, providing devices and software that help patients manage conditions such as sleep apnoea.

The company’s shares have been caught up in the market selloff in 2026 and recently hit a 52-week low. However, the underlying business remains strong, with continued growth in device sales, margin expansion, and a large, underdiagnosed patient population.

As the market volatility fades and investors refocus on fundamentals, ResMed could be well placed to rebound. Its combination of recurring revenue and structural growth drivers makes it an appealing long-term option.

WiseTech Global Ltd (ASX: WTC)

A third ASX share to consider before the next market rally is WiseTech Global.

WiseTech provides software solutions that help manage global supply chains, with its CargoWise platform used by logistics companies around the world.

Its software is deeply embedded in customer operations, creating high switching costs and a steady stream of recurring revenue. This gives the company a strong competitive position in a complex and essential industry.

Its shares have pulled back materially from previous highs, but its long-term growth story remains intact. As global trade continues to digitise, WiseTech is well placed to benefit.

If market sentiment continues to improve, companies like WiseTech with strong fundamentals and global exposure could be among those leading the next rally.

The post 3 ASX shares to buy before the next market rally appeared first on The Motley Fool Australia.

Should you invest $1,000 in CSL right now?

Before you buy CSL shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

See the 5 Stocks

* Returns as of 20 Feb 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor James Mickleboro has positions in CSL, ResMed, and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, ResMed, and WiseTech Global. The Motley Fool Australia has positions in and has recommended ResMed and WiseTech Global. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More posts